4//SEC Filing
GALLOWAY CHRISTOPHER D 4
Accession 0001437749-20-021435
CIK 0001053691other
Filed
Oct 20, 8:00 PM ET
Accepted
Oct 21, 8:04 PM ET
Size
5.8 KB
Accession
0001437749-20-021435
Insider Transaction Report
Form 4
GALLOWAY CHRISTOPHER D
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-10-19+200,000→ 200,000 totalExercise: $0.85Exp: 2030-10-19→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]In connection with the Reporting Person's new employment with the Issuer, the Compensation Committee of the Issuer's Board of Directors approved the grant of non-qualified stock options to the Reporting Person. The grant was made as an inducement material to the Reporting Person's acceptance of employment with the Issuer, in accordance with NASDAQ Listing Rule 5635(c)(4).
- [F2]The shares underlying the options will vest in 36 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a 36-month period beginning November 30, 2020.
Documents
Issuer
Diffusion Pharmaceuticals Inc.
CIK 0001053691
Entity typeother
Related Parties
1- filerCIK 0001829319
Filing Metadata
- Form type
- 4
- Filed
- Oct 20, 8:00 PM ET
- Accepted
- Oct 21, 8:04 PM ET
- Size
- 5.8 KB